Veltassa is a revolutionary new medication used to treat high levels of potassium in the blood. But who is behind this innovative new drug? In this article, we will take a closer look at the company responsible for bringing Veltassa to market. We’ll explore the history of the company, their mission, and the work they do to develop new drugs and treatments. So, without further ado, let’s dive into the world of Veltassa and the company that makes it.
Veltassa is a prescription medication manufactured by Relypsa, Inc. The company is a subsidiary of Galencia AG and is based in Switzerland. Veltassa is the only FDA approved treatment for hyperkalemia, which is a condition caused by abnormally high levels of potassium in the blood. It is available in both tablet and capsule form. Veltassa works by binding to potassium in the gut and preventing it from being absorbed into the bloodstream. This helps to reduce potassium levels in the blood and reduce symptoms associated with hyperkalemia.
Who Manufactures Veltassa?
Veltassa is a prescription medication used to treat hyperkalemia, a condition in which the body has too much potassium in the blood. It is manufactured by Relypsa, Inc., a biopharmaceutical company based in Redwood City, California.
History of Relypsa
Relypsa was founded in 2010 by Dr. John Orwin, a veteran of the biopharmaceutical industry. The company was initially focused on developing treatments for cardiovascular and metabolic diseases, but soon shifted its focus to hyperkalemia after acquiring the rights to Veltassa from Vifor Pharma in 2013.
Veltassa Manufacturing Process
Veltassa is manufactured using a process called spray drying. In this process, the active ingredient, patiromer, is suspended in a solution, which is then atomized into a hot air stream, causing the solution to evaporate and form a dry powder. The dry powder is then collected, milled, and tested for quality and consistency before being packaged and shipped to pharmacies.
Veltassa Quality Control
Relypsa is committed to providing a safe and effective product. To that end, they have implemented a rigorous quality assurance process to ensure that all of their products meet the highest standards. This includes in-process testing and quality controls to ensure that each batch of Veltassa is free of contamination and meets the required specifications. The company also conducts regular audits of its manufacturing processes to ensure that they are in compliance with all applicable laws and regulations.
Frequently Asked Questions
Q1: Who Makes Veltassa?
A1: Veltassa is made by Relypsa, Inc., a biopharmaceutical company. Relypsa is focused on developing treatments for conditions that affect the kidney and other organs. Veltassa was approved by the U.S. Food and Drug Administration in October 2016, and is the only FDA-approved treatment available for the treatment of hyperkalemia. Hyperkalemia is a medical condition characterized by an abnormally high level of potassium in the blood. Veltassa works by binding to potassium in the gastrointestinal tract, and therefore reducing the amount of potassium absorbed into the bloodstream. Veltassa is available as a powder that is mixed with water and taken orally once daily.
Veltassa demonstrates lower potassium levels in patients with hyperkalemia
Veltassa is a revolutionary medication that has been proven to be effective in treating hyperkalemia, a condition characterized by abnormally high levels of potassium in the blood. Developed by Relypsa, Inc., Veltassa is one of the few medications available to successfully treat hyperkalemia. With its innovative, patented polymer technology, Veltassa has been proven to be safe and effective in helping to reduce high potassium levels in the blood. By providing a much-needed solution to a serious medical condition, Relypsa, Inc. has made a significant contribution to the health and wellbeing of those affected by hyperkalemia.